Procurement

Rhetoric first, action later: the G7 approach to global equity

Mon, 02/22/2021 - 22:46
The G7 countries met (virtually) on Friday, February 19, to share variants of “no one is safe until everyone is safe” and discuss the importance of global equity of Covid-19 vaccines and the need for international cooperation. (Sound familiar? That’s because we heard the same things from the G20 in November.) 

Direct COVID vaccine deals by poorer countries are an important and encouraging development

Tue, 01/19/2021 - 13:00
This past week, we saw the first direct vaccine purchases made for low-income countries with the African Union’s purchase of 270 million doses of Covid-19 vaccines from Pfizer-BioNTech, OxfordAstraZeneca, and Johnson & Johnson (J&J). Though it is a relatively modest purchase, it represents a significant shift in the global power dynamics of the Covid-19 response.

Changing how India's vaccine numbers are represented in our data

Mon, 01/11/2021 - 13:00
The Serum Institute of India (SII), one of the world’s largest vaccine manufacturers, has publicly committed that half of the Covid-19 vaccines they produce will stay in India to serve the domestic market, while the remainder will be shipped out to other countries. This week, we have changed the way that India’s reserved doses of vaccine are represented in our data.